Calorie Restriction Retards the Aging Process
|ClinicalTrials.gov Identifier: NCT01508091|
Recruitment Status : Unknown
Verified October 2012 by MARIA PIA DE LA MAZA, University of Chile.
Recruitment status was: Recruiting
First Posted : January 11, 2012
Last Update Posted : October 23, 2012
|Condition or disease||Intervention/treatment|
|Obesity||Behavioral: energy restricted mediterranean-type diet Behavioral: 25 % calorie restriction|
Hide Detailed Description
HYPOTHESIS: Calorie restriction delays the ageing process and thus telomere erosion, due to a reduction of oxidative stress, via expression modulation of uncoupling proteins and sirtuins.
Approximately 1000 adults aged 40 to 55 years, that had participated in nutritional assessments studies during which their body weight was recorded, and had a body mass index (BMI) of less than 30 kg/m2 at that time will be considered eligible. Other sources of subject recruitment will be health records from armed forces personnel and our institutional data base. Those that accept and sign a written informed consent, will be subjected to:
- A complete clinical history, recording past and present diseases, medication use, history of smoking, drinking and illicit drug use.
- A dietary questionnaire to assess nutrient intake
- A complete clinical examination including the measurement of body weight, height, blood pressure.
- A physical activity questionnaire previously validated by us 1
- Measurement of body composition by DEXA
Withdrawal of a 10 hours fasting blood sample of 30 ml to measure
- Packed red cell volume, blood glucose, creatinine, serum lipids, TSH, thyroid hormones and insulin
- Telomere length in peripheral blood mononuclear cells (PBMC)
- Sirt1 and 6 gene expression in PBMC.
- Plasma 8‐ isoprostanes
- Measurement of carotid intima media thickness by ultrasound, performed by a trained professional using previously reported protocols.
Once evaluated, subjects will be classified as:
- Weight maintainers if their actual weight is, at the most within 10% of the weight recorded at least 10 years before
- Weight gainers, if their actual weight is over 20% of the weight previously recorded
The following will be excluded from further analysis:
- Subjects with a history of chronic debilitating diseases such as renal failure, cancer, autoimmune diseases,hypothyroidism, diabetes mellitus or AIDS.
- Subjects engaged in extremely high physical activity (more than 10 hour per week of sports or work requiring extreme physical activity such as shoveling or hard manual work.
- Subjects with a history of drug abuse or alcoholism
- Subjects using anorexigenic or anabolic drugs, or chronic users of non steroidal anti‐inflammatory drugs.
- Subjects smoking more than 5 cigarettes per day (91 packs per year)
- Overly malnourished subjects, defined as a body mass index below 18 kg/m2.
To study the effects of a three month period of calorie restriction in normal volunteers on the expression of expression of SIRT1 and UCP3 in muscle, SIRT6 in PBMC, brown adipose tissue activity and the accumulation of markers of oxidative damage.
- To develop a prospective model of calorie restriction in normal human volunteers.
To study changes associated with calorie restriction on:
- Serum markers of inflammation and free fatty acids during fasting.
- The uptake of 18fluorodexoyglucose by brown adipose tissue measured by PET‐CT
- The expression of mRNA of UCP3 and SIRT1 in muscle biopsies.
- The expression of mRNA for SIRT1 and 6 in muscle and peripheral blood mononuclear cells
- The accumulation of 4 hydroxynonenal and 8 hydroxyguanosine in muscle, as markers of oxidative damage
- The production of ROS by peripheral neutrophils as an overall measure of the capacity to generate free radicals
- Insulin sensitivity, measured using formula derived from glucose tolerance. METHODOLOGY Premenopausal women, aged 25 to 40 years, with a BMI between 27 and 32 kg/m2, interested in losing weight, will be studied. Inclusion criteria will be: complete high school, stable weight (± 2 kg) in the last six months, and absence of diabetes, medication intake that could influence energy expenditure such as beta blockers (except oral contraceptives) and lack of engagement in competitive or exhausting physical activities. Women will be required to use an effective contraceptive method, and a pregnancy test will be performed every month while the study lasts.
After signing an informed consent form, total energy expenditure will be measured through calorimetry and actigraphy or doubly labeled water. Subjects will be considered to be in energy balance, taking into account that weight is stable (the lack of weight change will be assessed during the two weeks required for inclusion studies). Therefore, it can be assured that energy intake at that moment is equal to total energy expenditure .
Afterwards, subjects subjected to a 25% restriction of their measured total energy expenditure (this level of restriction has been well tolerated by volunteers, even during one year). Restriction will be balanced, using a mediterranean type diet, maintaining a proportion of 50% carbohydrates, 25-30% of lipids, 25% of proteins and a provision of 100% of micronutrient requirements. Patients will attend to dietician reinforcement every week. To ease the restriction period, one extra meal will be allowed once a week. According to weight change, volunteers will be considered as energy restricted (group 1) is they loose at least 3 kg or 5 % weight during the study period. Instead those subjects that do not reach these goals will be considered as the control group (Group 2).
The intervention will last three months and will be carried out during a period in which temperature remains relatively stable and is lower, in Santiago Chile, to avoid an effect of climate on brown adipose tissue activity. The ideal will be between May and August. Both groups will be evaluated on a weekly basis by a nutritionist to assess compliance with the diet, reinforce indications and be weighed. Subjects will receive a monthly monetary remuneration in order to permit the purchase of specific foods and brands prescribed. Each subject will be educated about healthy dietary and physical activity lifestyle. Eventual changes in physical activity which will be ascertained using portable actigraphs (Actiheart®).
Apart from weight change, volunteers will be considered as calorie restricted if triglyceride levels decrease at least 15% and T3 levels are reduced by at least 8 ng/dl.
At baseline, and the end of the three month intervention period in which controls should be in zero energy balance and adherent subjects in negative energy balance, the following determinations will be carried out:
- Measurement of routine clinical laboratory parameters to discard concomitant diseases.
- Measurement of fasting serum free fatty acids.
- Measurement of ultrasensitive C reactive protein and carboxymethyllisine (CML) as an inflammation marker and glycotoxin respectively, using commercial ELISA kits.
- Measurement of triglyceride and T3 levels to assess compliance with calorie restriction.
- Glucose tolerance curve to measure glucose and insulin and calculate insulin sensitivity using Matsuda formula
- Measurement of oxidative burst of peripheral neutrophils by Fluorescence Activated Cell Sorting (FACS) as an expression of ROS production capacity of the organism
- Measurement of SIRT1 and 6 gene expression in PBMC by RT‐PCR according to the technique reported by Crujeiras et al
- PET CT to measure 18fluorodeoxyglucose uptake by supraclavicular fat in thermoneutral conditions and after immersing one foot in water at 8°C during five minutes, according to Virtanen et al.
Vastus lateralis muscle biopsy, performed by a physician using a Bard needle using a technique previously reported buy our group (this is a safe and simple procedure but the biopsy sample obtained is small, therefore the analyses that can be performed are limited), to measure:
- mRNA for UCP3 by RT‐PCR , using the technique reported by Millet et al in biopsies obtained in a similar way in humans.
- mRNA for SIRT1 by RT‐PCR using the technique reported by Heilbronn et al.
- Immunohistochemical expression of 8 hydroxyguanosine and 4 hydroxynonenal as oxidation markers, using methods previously reported by us.
- Body composition measurement by double energy X ray absorptiometry (DEXA).
- Resting energy expenditure measurement in and open‐circuit indirect calorimeter (model 2900, Sensor Medics Corp., Yerba Linda, CA, USA).
- Actigraphy using Actiheart actigraphs to assess eventual changes in spontaneous physical activity induced by calorie restriction.
Telomere length will not be measured in the prospective protocol, considering that not changes will be detected in the short study period.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||48 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Basic Science|
|Official Title:||Calorie Restriction Retards the Aging Process by Inducing Sirtuins and Uncoupling Protein 3, Thereby Reducing the Production of Reactive Oxygen Species.|
|Study Start Date :||May 2012|
|Estimated Primary Completion Date :||December 2012|
|Estimated Study Completion Date :||June 2013|
Experimental: Calorie restricted
25 % calorie restriction respect measured total energy expenditure, using a Mediterranean diet
Behavioral: energy restricted mediterranean-type diet
Prescription of diet 25 % lower than actual total energy expenditure in overweight or moderately obese premenopausal women
Other Names:Behavioral: 25 % calorie restriction
25 % calorie restriction respect total energy expenditure
- UCP3 mRNA expression in vastus lateralis after energy restriction [ Time Frame: 3 months ]The main outcome measure will be UCP3 mRNA expression in vastus lateralis, which will be measured before and after the 3 month intervention period. This enzyme is the last link in the chain of events that occur after calorie restriction. Millet et al reported a value for UCP3 mRNA of 15 ± 1.5 amol/ìg total RNA in 18 subjects. Expecting a 60% increase over baseline in the expression of the enzyme, 17 subjects per group are required to obtain results with an á of 0.05 and a power of 0.8. Considering attrition rates, we must study 24 subjects per group.
- Brown adipose tissue (BAT) activity, indicating UCP1 expression after calorie restriction [ Time Frame: 3 months ]Active BAT and its activation with cold exposure in humans, was demonstrated measuring 18 fluorodeoxyglucose uptake using PET‐CT and colocalized the areas of 18F‐FDG uptake to the expression of UCP1 thus for practical purposes it is a non invasive and reliable method to detect the presence of the tissue and the activity of UPC1, whic is downregulated by energy restriction.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01508091
|Contact: Maria Pia de la Maza, MDfirstname.lastname@example.org|
|Contact: Daniel Carlos Bunout, MDemail@example.com|
|Clinica Alemana de Santiago||Recruiting|
|Santiago, Region Metropolitana, Chile|
|Contact: Pablo Lavados, MD firstname.lastname@example.org|
|Contact: Claudio Mizon, MD 56996321586 email@example.com|
|Sub-Investigator: Claudio Mizon, MD|